ACT Capital Management »

Medicenna Therapeutics Corp. shares owned by ACT Capital Management

Quarter-by-quarter ownership of Medicenna Therapeutics Corp. (MDNAF) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Medicenna Therapeutics Corp.

Tip: Access up to 7 years of quarterly data

All positions including Medicenna Therapeutics Corp. held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medicenna Therapeutics Corp. by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $124k 149k 0.83
2022-06-30 $173k 149k 1.16
2022-03-31 $195k 153k 1.28
2021-12-31 $249k 153k 1.63
2021-09-30 $970k 350k 2.77
2021-06-30 $1.1M 350k 3.01

More positions owned by ACT Capital Management

STAAR Surgical Company (STAA)
Exxon Mobil Corporation (XOM)
Devon Energy Corporation (DVN)
Krystal Biotech (KRYS)
Arrowhead Pharmaceuticals (ARWR)
Axsome Therapeutics (AXSM)
Chevron Corporation (CVX)
Adtran Holdings (ADTN)
Envveno Medical (NVNO)
Clearside Biomedical (CLSD)
Laredo Petroleum (VTLE)
Arcturus Therapeutics Hldg I (ARCT)
Eiger Biopharmaceuticals
Verona Pharma Sponsored Ads (VRNA)
Energy Transfer Com Ut Ltd Ptn (ET)

View all positions for ACT Capital Management

Top funds holding Medicenna Therapeutics Corp.

ORG Partners

View all funds holding Medicenna Therapeutics Corp.